Clinical Report: Sarcopenia and Nutritional Support in Pediatric ALL

Overview

This study evaluates the relationship between computed tomography-derived sarcopenia, enteral nutritional support, and febrile neutropenia in children with acute lymphoblastic leukemia. Findings indicate a high prevalence of sarcopenia but no significant association with febrile neutropenia burden or hospital stay.

Background

Expand on the implications of sarcopenia on treatment outcomes in pediatric oncology.

Data Highlights

Key Findings

• Sarcopenia was present in 80% of children assessed via CT imaging.
• No significant association was found between sarcopenia and febrile neutropenia frequency, severe neutropenia, mortality, or hospital stay.
• Enteral nutritional support was linked to a higher burden of febrile neutropenia but not interpreted as causal.
• Febrile neutropenia-related mortality occurred in 17 patients within the cohort.
• Exploratory analysis suggested a borderline association between enteral nutritional support and febrile neutropenia frequency (IRR: 1.16, p = 0.052).

Clinical Implications

Clinicians should be aware of the high prevalence of sarcopenia in pediatric patients with ALL and consider it a marker of clinical vulnerability rather than a direct cause of febrile neutropenia. Nutritional support strategies should be tailored to address the complex needs of these patients, focusing on overall clinical management rather than solely on nutritional metrics.

Conclusion

The findings highlight the importance of assessing sarcopenia in pediatric oncology, particularly in ALL, while emphasizing that enteral nutritional support should be viewed in the context of overall clinical severity rather than as a causal factor for febrile neutropenia.

Related Resources & Content

1. European Radiology, 2024 -- Automated Evaluation of Body Composition in Pediatric Lymphoma Patients
2. Muscle Mass and Sarcopenia Do Not Serve as Prognostic Indicators for Outcomes Following Esophagectomy in Cancer Patients, 2016
3. Blood Cancer Journal, 2017 -- The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia
4. Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer, 2023
5. Diagnostic criteria, prevalence, and clinical outcomes of pediatric sarcopenia: A scoping review, 2024
6. European Radiology — Prognostic Significance of Initial EARL Standardized FDG PET Metrics in Pediatric and Adolescent High-Grade Osteosarcoma
7. Guideline for the Management of Fever and Neutropenia in Pediatric Patients
8. Managing Undernutrition in Pediatric Oncology
9. Diagnostic criteria, prevalence, and clinical outcomes of pediatric sarcopenia: A scoping review - ScienceDirect